These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 920058)

  • 21. Serum amyloid A and protein AA: molecular mechanisms of a transmissible amyloidosis.
    Westermark GT; Westermark P
    FEBS Lett; 2009 Aug; 583(16):2685-90. PubMed ID: 19393650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphism of tissue and serum amyloid A (AA and SAA) proteins in the mouse.
    Gorevic PD; Levo Y; Frangione B; Franklin EC
    J Immunol; 1978 Jul; 121(1):138-40. PubMed ID: 670697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic studies of familial amyloid polyneuropathy in the Arao district of Japan. III. Analysis of amyloid fibril protein.
    Ueji M; Suzuki T; Higa S; Sakoda S; Kishimoto S; Titani K; Takio K; Hayashi A; Takaba Y; Nakajima A
    Jinrui Idengaku Zasshi; 1984 Sep; 29(3):311-25. PubMed ID: 6533355
    [No Abstract]   [Full Text] [Related]  

  • 24. Amyloid fibril proteins found in Papua New Guinean and other amyloidoses.
    Anders RF
    P N G Med J; 1978 Mar; 21(1):79-85. PubMed ID: 286487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation and characterization of amyloid protein AA in the Abyssinian cat.
    DiBartola SP; Benson MD; Dwulet FE; Cornacoff JB
    Lab Invest; 1985 May; 52(5):485-9. PubMed ID: 3990242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphologic and chemical variation of the kidney lesions in amyloidosis secondary to rheumatoid arthritis.
    Westermark P; Sletten K; Eriksson M
    Lab Invest; 1979 Nov; 41(5):427-31. PubMed ID: 502474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amyloid goiter with hypothyroidism.
    Kanoh T; Shimada H; Uchino H; Matsumura K
    Arch Pathol Lab Med; 1989 May; 113(5):542-4. PubMed ID: 2712679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amyloid deposition in the thyroid gland in patients with amyloidosis: an incidence study with fine-needle aspiration biopsy of the thyroid.
    Ertürk S; Duman N; Ates K; Ekinci C; Erbay B; Karatan O; Erdoğan G; Ertuğ E; Dizbay Sak S
    Nephrol Dial Transplant; 1995; 10(8):1473. PubMed ID: 8538953
    [No Abstract]   [Full Text] [Related]  

  • 29. Characterization of spontaneous amyloidosis of Syrian hamsters using the potassium permanganate method.
    Mezza LE; Quimby FW; Durham SK; Lewis RM
    Lab Anim Sci; 1984 Aug; 34(4):376-80. PubMed ID: 6482376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of an amyloid fibril protein from localized amyloidosis of the skin as lambda immunoglobulin light chains of variable subgroup I (A lambda I).
    Husby G; Sletten K; Blumenkrantz N; Danielsen L
    Clin Exp Immunol; 1981 Jul; 45(1):90-6. PubMed ID: 6796317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of murine AA amyloidosis by various homogeneous amyloid fibrils and amyloid-like synthetic peptides.
    Liu Y; Cui D; Hoshii Y; Kawano H; Une Y; Gondo T; Ishihara T
    Scand J Immunol; 2007 Nov; 66(5):495-500. PubMed ID: 17953525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amyloid fibril protein in type I familial amyloidotic polyneuropathy in Japanese.
    Tawara S; Araki S; Toshimori K; Nakagawa H; Ohtaki S
    J Lab Clin Med; 1981 Dec; 98(6):811-22. PubMed ID: 7310224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product.
    Westermark GT; Sletten K; Grubb A; Westermark P
    Am J Pathol; 1990 Aug; 137(2):377-83. PubMed ID: 2386201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of amyloid of ageing obese-hyperglycaemic mice and their lean littermates.
    Westermark P; Sletten K; Naeser P; Natvig JB
    Scand J Immunol; 1979; 9(2):193-6. PubMed ID: 424703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The heterogeneity of protein AA in secondary (reactive)systemic amyloidosis.
    Westermark P
    Biochim Biophys Acta; 1982 Feb; 701(1):19-23. PubMed ID: 6173073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemical characteristics of the substance of typical amyloidosis in monkeys.
    Benditt EP; Eriksen N
    Acta Pathol Microbiol Scand Suppl; 1972; 233():103-8. PubMed ID: 4116385
    [No Abstract]   [Full Text] [Related]  

  • 37. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
    Nerelius C; Fitzen M; Johansson J
    Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent advances in studies on amyloid and amyloidosis (author's transl)].
    Uchino F
    Nihon Ika Daigaku Zasshi; 1981 Apr; 48(2):160-8. PubMed ID: 7028778
    [No Abstract]   [Full Text] [Related]  

  • 39. The potassium permanganate method. A reliable method for differentiating amyloid AA from other forms of amyloid in routine laboratory practice.
    van Rijswijk MH; van Heusden CW
    Am J Pathol; 1979 Oct; 97(1):43-58. PubMed ID: 495695
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Crystalline light-chain deposition and amyloidosis in the thyroid gland and kidneys of a patient with myeloma.
    Hirota S; Miyamoto M; Kasugai T; Kitamura Y; Morimura Y
    Arch Pathol Lab Med; 1990 Apr; 114(4):429-31. PubMed ID: 2108650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.